Roger Auth

726 total citations
10 papers, 71 citations indexed

About

Roger Auth is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Biotechnology. According to data from OpenAlex, Roger Auth has authored 10 papers receiving a total of 71 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Biotechnology. Recurrent topics in Roger Auth's work include Bacillus and Francisella bacterial research (4 papers), Cystic Fibrosis Research Advances (4 papers) and Microbial Inactivation Methods (3 papers). Roger Auth is often cited by papers focused on Bacillus and Francisella bacterial research (4 papers), Cystic Fibrosis Research Advances (4 papers) and Microbial Inactivation Methods (3 papers). Roger Auth collaborates with scholars based in United States. Roger Auth's co-authors include David M. Frucht, Tao Xie, Hui Fang, Chen Sun, Philip Snoy, James R. Klinger, Debasree Banerjee, Weiming Ouyang, Patrick R. Murray and Robert J. Owen and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and CHEST Journal.

In The Last Decade

Roger Auth

6 papers receiving 65 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Auth United States 6 48 27 21 18 11 10 71
Chi Ho Yu South Korea 6 23 0.5× 8 0.3× 7 0.3× 10 0.6× 7 0.6× 11 62
Eve L. Coomber United Kingdom 5 28 0.6× 8 0.3× 10 0.5× 16 0.9× 6 0.5× 6 76
Lee Davies United Kingdom 7 49 1.0× 8 0.3× 35 1.7× 16 0.9× 8 0.7× 12 84
Richard Tarrant United Kingdom 6 159 3.3× 9 0.3× 28 1.3× 15 0.8× 2 0.2× 7 183
Xiaoying Yu United States 7 60 1.3× 6 0.2× 8 0.4× 38 2.1× 6 0.5× 9 110
Ye‐Fan Hu China 8 53 1.1× 6 0.2× 5 0.2× 48 2.7× 7 0.6× 13 135
Daniel Carbajo Singapore 2 21 0.4× 8 0.3× 3 0.1× 32 1.8× 3 0.3× 3 173
Mabel Lum Australia 4 39 0.8× 8 0.3× 15 0.7× 10 0.6× 5 75
Edgar Tello‐Ruiz United States 4 38 0.8× 11 0.4× 6 0.3× 18 1.0× 1 0.1× 5 84
Thibaud Jourdan Germany 4 18 0.4× 3 0.1× 4 0.2× 12 0.7× 5 0.5× 6 75

Countries citing papers authored by Roger Auth

Since Specialization
Citations

This map shows the geographic impact of Roger Auth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Auth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Auth more than expected).

Fields of papers citing papers by Roger Auth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Auth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Auth. The network helps show where Roger Auth may publish in the future.

Co-authorship network of co-authors of Roger Auth

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Auth. A scholar is included among the top collaborators of Roger Auth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Auth. Roger Auth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Auth, Roger, et al.. (2023). Perceptions and Use of E-cigarettes among Young Adults with Cystic Fibrosis: An Observational Study.. PubMed. 106(7). 58–63. 1 indexed citations
3.
Auth, Roger, et al.. (2023). Integrating Primary Care into the Management of Cystic Fibrosis. Journal of Primary Care & Community Health. 14. 4277793971–4277793971. 7 indexed citations
4.
Auth, Roger & James R. Klinger. (2023). Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension. Expert Opinion on Investigational Drugs. 32(11). 1025–1042. 6 indexed citations
5.
Auth, Roger, et al.. (2021). Things We Do for No Reason™: Routine use of corticosteroids for the treatment of anaphylaxis. Journal of Hospital Medicine. 17(3). 211–214.
6.
Banerjee, Debasree, et al.. (2020). ASSESSMENT OF VAPING PRACTICES IN PATIENTS WITH CYSTIC FIBROSIS. CHEST Journal. 158(4). A1055–A1055.
7.
Xie, Tao, Chen Sun, Roger Auth, et al.. (2013). A New Murine Model for Gastrointestinal Anthrax Infection. PLoS ONE. 8(6). e66943–e66943. 12 indexed citations
8.
Sun, Chen, Hui Fang, Tao Xie, et al.. (2012). Anthrax Lethal Toxin Disrupts Intestinal Barrier Function and Causes Systemic Infections with Enteric Bacteria. PLoS ONE. 7(3). e33583–e33583. 17 indexed citations
9.
Xie, Tao, Roger Auth, & David M. Frucht. (2011). The Effects of Anthrax Lethal Toxin on Host Barrier Function. Toxins. 3(6). 591–607. 17 indexed citations
10.
Fang, Hui, Chen Sun, Lixin Xu, et al.. (2010). Neutrophil Elastase Mediates Pathogenic Effects of Anthrax Lethal Toxin in the Murine Intestinal Tract. The Journal of Immunology. 185(9). 5463–5467. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026